Cargando…
Prediction of opioid dose in cancer pain patients using genetic profiling: not yet an option with support vector machine learning
OBJECTIVE: Use of opioids for pain management has increased over the past decade; however, inadequate analgesic response is common. Genetic variability may be related to opioid efficacy, but due to the many possible combinations and variables, statistical computations may be difficult. This study in...
Autores principales: | Olesen, Anne Estrup, Grønlund, Debbie, Gram, Mikkel, Skorpen, Frank, Drewes, Asbjørn Mohr, Klepstad, Pål |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787255/ https://www.ncbi.nlm.nih.gov/pubmed/29374492 http://dx.doi.org/10.1186/s13104-018-3194-z |
Ejemplares similares
-
Clinical potential of naloxegol in the management of opioid-induced bowel dysfunction
por: Poulsen, Jakob Lykke, et al.
Publicado: (2014) -
Gender, variation in opioid receptor genes and sensitivity to experimental pain
por: Sato, Hiroe, et al.
Publicado: (2013) -
Sensitivity of quantitative sensory models to morphine analgesia in humans
por: Olesen, Anne Estrup, et al.
Publicado: (2014) -
Cingulate metabolites during pain and morphine treatment as assessed by magnetic resonance spectroscopy
por: Hansen, Tine Maria, et al.
Publicado: (2014) -
Genetic variation and cognitive dysfunction in opioid‐treated patients with cancer
por: Kurita, Geana Paula, et al.
Publicado: (2016)